ADaM Reviewer’s Guide

(Pre-filled Example – Oncology Phase II)

Study ID: ONC-201
Indication: Metastatic Non-Small Cell Lung Cancer (NSCLC)
Submission Type: NDA
ADaM Standard: ADaM v2.1
Date: 15-Mar-2026


1. Purpose of This ADaM Reviewer’s Guide

This ADaM Reviewer’s Guide provides an overview of the analysis datasets, their structure, and key derivations, and describes traceability from SDTM to ADaM.
It is intended to help reviewers understand how the ADaM datasets were constructed and how they support statistical analyses, without restating the SAP.


2. Overview of ADaM Datasets

ADaM Dataset

Description

Granularity

ADSL

Subject-level analysis dataset

One record per subject

ADAE

Adverse event analysis dataset

One record per AE per subject

ADLB

Laboratory analysis dataset

One record per test per visit per subject

ADTTE

Time-to-event analysis dataset

One record per subject per parameter


3. Subject-Level Analysis Dataset (ADSL)

3.1 Dataset Description

ADSL contains one record per subject and includes treatment assignments, population flags, and baseline demographic variables.
All other ADaM datasets are linked to ADSL via
USUBJID.

3.2 Key Variables

Variable

Description

USUBJID

Unique subject identifier

TRT01A

Actual treatment received

ITTFL

Intent-to-treat population flag

SAFFL

Safety population flag

PPFL

Per-protocol population flag

AGE, SEX

Demographics

RFSTDTC

Reference start date


4. Adverse Events Analysis Dataset (ADAE)

4.1 Dataset Description

ADAE is derived from the SDTM AE domain and includes one record per adverse event per subject.
It supports all safety analyses.

4.2 Key Variables

Variable

Description

AETERM

Adverse event term

AESEV

Severity

AESER

Serious AE flag

ASTDT

AE start date (numeric)

AENDT

AE end date (numeric)

TRTEMFL

Treatment-emergent AE flag

4.3 Key Derivations


5. Laboratory Analysis Dataset (ADLB)

5.1 Dataset Description

ADLB is derived from the SDTM LB domain and includes one record per laboratory test per visit per subject.
Both numeric and character results are retained.

5.2 Key Variables

Variable

Description

PARAMCD

Laboratory test code

PARAM

Laboratory test name

AVAL

Numeric analysis value

AVALC

Character analysis value

BASE

Baseline value

CHG

Change from baseline

AVISIT

Analysis visit

5.3 Baseline Definition

Baseline is defined as the last non-missing laboratory value prior to first dose.


6. Time-to-Event Analysis Dataset (ADTTE)

6.1 Dataset Description

ADTTE supports time-to-event analyses such as Progression-Free Survival (PFS).

6.2 Key Variables

Variable

Description

PARAMCD

Parameter code (e.g., PFS)

AVAL

Analysis time (days)

CNSR

Censoring indicator

EVNTDESC

Event description


7. Analysis Populations

Population flags are defined in ADSL and propagated to all other ADaM datasets.

Population

Flag

Definition

ITT

ITTFL='Y'

All randomized subjects

Safety

SAFFL='Y'

Subjects receiving ≥1 dose

PP

PPFL='Y'

ITT subjects without major protocol deviations


8. Traceability from SDTM to ADaM

8.1 SDTM → ADaM Mapping Examples

ADaM Dataset

ADaM Variable

SDTM Domain

SDTM Variable(s)

Derivation

ADSL

TRT01A

DM

ARM

Assigned

ADAE

AETERM

AE

AEDECOD

Copied

ADAE

ASTDT

AE

AESTDTC

Converted

ADLB

AVAL

LB

LBSTRESN

Copied

ADTTE

AVAL

AE, RS

Event dates

Derived


9. Value-Level Metadata Highlights

Value-level metadata are used where variable attributes differ by parameter.

Dataset

Variable

Condition

Description

ADLB

AVAL

PARAMCD=ALB

Numeric, 1 decimal

ADLB

AVALC

PARAMCD=HBsAg

Character POS/NEG


10. Known Data Considerations

Issue ID

Description

Impact

ADAM-01

Missing baseline labs for some subjects

Subjects excluded from baseline analyses

ADAM-02

Partial AE end dates

Conservative imputation applied


11. Relationship to Other Documents


One-sentence takeaway

The ADaM Reviewer’s Guide explains how the analysis datasets are structured, derived, and linked to SDTM, enabling reviewers to understand and trace the analysis data without relying on statistical code.